Search Medical Condition
Please enter condition
Please choose location from dropdown

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1524) clinical trials

If so, call Boston Clinical Trials at 617-477-4868 and ask about our research study of investigational medication for depression. Located in Roslindale Village.Evening appointments available.Free parking. Compensation provided. www.bostontrials.com

Phase N/A

Dr. Charles Conway is conducting a research study looking at adaptive enhanced transcranial direct current stimulation (tDCS) as adjunctive therapy for major depression. This study lasts 6 weeks. There will be up to 24 study visits that will last 30 minutes to 3 hours each. Participants will undergo 20 sessions ...

Phase N/A

The Atlanta Center for Medical Research is enrolling volunteers with major depressive episodes associated with Bipolar I or Bipolar II Disorder (Bipolar Depression) in a study testing an investigational medication.

Phase N/A

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Phase

This study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive treatment to ongoing anti-depressive therapy (ADT) in the prevention of relapse in participants with Major Depressive Disorder (MDD).

Phase

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Phase

Adults experiencing depression associated with bipolar disorder have the opportunity to participate in a clinical trial studying the efficacy of a new, investigational medication. Qualified participants will receive study medication and will be closely followed by UC Health staff over 6 weeks.

Phase N/A

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MUTLICENTER STUDY OF RAPASTINEL AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER

Phase

A MULTICENTER, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Phase

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF ITI-007 MONOTHERAPY IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR I OR II DISORDER (BIPOLAR DEPRESSION)

Phase